Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market
As the global economy mends, the 2021 growth of 13-Valent Pneumococcal Polysaccharide Conjugate V ... Read More
As the global economy mends, the 2021 growth of 23-valent Pneumococcal Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global 23-valent Pneumococcal Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global 23-valent Pneumococcal Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States 23-valent Pneumococcal Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global 23-valent Pneumococcal Vaccine market, reaching US$ million by the year 2028. As for the Europe 23-valent Pneumococcal Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main 23-valent Pneumococcal Vaccine players cover Merck, Sanofipasteur, CDIBP, and Kexing Bio, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of 23-valent Pneumococcal Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Single Dose Vial
Pre-filled Syringe
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Chronic Cardiovascular Disease
Chronic Lung Disease
Chronic Liver Disease
People Living with Hiv
Leukemia
Lymphoma
Multiple Myeloma
General Malignancy
Chronic Kidney Disease
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Sanofipasteur
CDIBP
Kexing Bio
Changsheng Bio-Technology
Huaan Science and Technology Innovation
As the global economy mends, the 2021 growth of 13-Valent Pneumococcal Polysaccharide Conjugate V ... Read More
As the global economy mends, the 2021 growth of Hot and Sour Noodles will have significant change ... Read More
As the global economy mends, the 2021 growth of Automotive Exhaust Catalytic Materials will have ... Read More